HealthCare Global Enterprises Limited and Accenture collaborate on cancer research and care using advanced AI

HealthCare Global Enterprises Limited (HCG) is collaborating with Accenture to accelerate cancer research and care through the use of advanced AI, including generative AI and deep learning on multi-dimensional and multi-omic patient data. This strategic teaming combines Accenture’s global expertise and talent in data and AI including AI/ML, generative AI, and quantum computing with deep clinical insights from HCG in oncology to enable early detection and treatment for various types of cancer.

As part of the joint effort, Accenture will use advanced technologies including image analysis software, informatics, and novel algorithms to analyse data from cancer patients and study molecular alterations that can have a broader impact on patient care. The program, the first of its kind in South Asia, will leverage Accenture’s generative AI studios to spur innovative research for the discovery and development of new drug targets, mechanisms and pathways, and biomarkers associated with different ...